Nasdaq Moves to Delist Fractyl Health; Company to Request Hearing
GUTS sits 73% above its 52-week low of $0.377.
Summary
Fractyl Health received a formal delisting notice from Nasdaq on September 10, 2026, after failing to regain compliance with the $1.00 minimum bid price rule. The company will request a hearing to stay the delisting while it pursues a reverse stock split.
Key Events · Legal and Risk Events · GUTS
-
Nasdaq Delisting Notice Received
On September 10, 2026, Nasdaq notified Fractyl Health that its securities are subject to delisting after the company failed to regain compliance with the $1.00 minimum bid price requirement within the 180-day grace period.
-
Hearing Request to Stay Delisting
The company intends to timely request a hearing before a Nasdaq Hearings Panel, which will automatically stay any suspension or delisting pending the conclusion of the hearings process.
-
Reverse Split Vote Looms
Shareholders vote September 24, 2026 on a 1-for-5 to 1-for-15 reverse stock split, which is the company's primary mechanism to regain compliance with the minimum bid price requirement.
-
Compliance Path Defined
To regain compliance, the closing bid price must be at least $1.00 per share for at least 10 consecutive business days, and up to 20 consecutive business days at Nasdaq staff's discretion.
Analysis · GUTS · Industrial Applications And Services
The listing crisis at Fractyl Health has reached a critical juncture. Nasdaq formally notified the company on September 10, 2026 that its securities are subject to delisting after it failed to regain compliance with the $1.00 minimum bid price requirement within the 180-day grace period. The company intends to request a hearing, which will automatically stay the delisting pending the hearings process. This development comes just two weeks before the September 24 shareholder vote on a reverse stock split that is intended to restore compliance. The delisting notice confirms that the company's survival on Nasdaq now depends on both the hearing outcome and the reverse split approval.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 41.8% of the 507 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GUTS was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $101.9M. The 52-week trading range was $0.38 to $2.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.